Expired activity
Please go to the PowerPak
homepage and select a course.
Management of Multiple Myeloma Through an Interprofessional Approach: Utilization of Treatment Combinations and Sequencing of Regimens
Provided by American Academy of CME, Inc.
This educational activity is supported by an educational grant from Sanofi Genzyme.
Release date
December 11, 2019
Expiration date
December 11, 2020
Estimated time to complete activity
1.5 hours
Activity Description
Multiple myeloma (MM) continues to be a pervasive disease that is encountered by the oncology care team. The treatment paradigm for this disease continues to evolve, with new treatment schemas and combination regimens continuing to emerge. As such, individuals with MM have more options for treatment of their disease and longevity has increased. Based on the constant evolution in the setting of MM, it's important for the members of the care team to remain cognizant of their patient's treatment options and indicated supportive care strategies. This requires an orchestrated back-and-forth between multiple healthcare professionals – including nurses, pharmacists, and physicians – to discuss the patient's clinical status, goals of therapy, optimal treatment approach, and ability to tolerate therapy. Additionally, the care team should consider the patient from a holistic approach, ensuring they have adequate support not only from a pharmacology perspective, but also from a financial and psychosocial context. Patients may suffer a severe psychological and monetary burden from the treatment of their disease, and so it's important to gauge these elements to ensure individuals can continue therapy without significantly affecting their quality of life.
Faculty Educators
Marcus Flores, PharmD, BCPS, BCOP
Clinical Pharmacist, Oncology
Hackensack Meridian Health Cancer Care
Jersey Shore University Medical Center
Suzanne Penna, MSN, RN, OCN
Clinical Nurse Specialist
Middletown, NJ
Target Audience
The target audiences for this initiative include oncology pharmacists, oncology nurses, nurse practitioners and nurse navigators actively engaged in patient care. Other members of the care team may also participate.
Educational Objectives
Upon completing this activity, learners should be better able to:
- Identify new medication regimens for the treatment of MM and their tier in therapy
- Describe adverse events and management strategies of medications used to treat MM
- Review the supportive care needs of MM patients based on their medication regimen and comorbidities
- Describe strategies to reduce the risk of skeletal, thrombotic, and infectious complications in MM
- Discuss the roles of the interprofessional cancer team in MM treatment and management
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. American Academy of CME, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This activity provides 1.5 ACPE contact hours (0.15 CEUs) of continuing education credit.
Universal Activity Number JA4008191-0000-19-014-H01-P, Application
Nurses and Nurse Practitioners
American Academy of CME, Inc., designates this educational activity for 1.5 ANCC contact hours (0.75 pharmacotherapeutic contact hours).
California
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.
Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are able to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Faculty Educators
Marcus Flores, Pharm.D., BCPS, BCOP
No relevant financial relationships with any commercial interests.
Suzanne Penna, MSN, RN, OCN
No relevant financial relationships with any commercial interests.
Planning Committee
John JD Juchniewicz, MCIS, CHCP, Edward Moylan, RPh, Natalie Kirkwood, JD, BSN, RN Wendy Gloffke, PhD and Paul Miniter, MS - No relevant financial relationships with any commercial interests.
This activity will review off-label or investigational information
Disclaimer
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CPE/CNE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only pharmacist learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.
Hardware/Software Requirements
Please ensure the computer you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5
Privacy
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm
Contact
For any questions, please contact: CEServices@academycme.org
Copyright
© 2019. This CPE/CNE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
